EP1675506B1 - Systeme pour detecter des variations fluidiques - Google Patents
Systeme pour detecter des variations fluidiques Download PDFInfo
- Publication number
- EP1675506B1 EP1675506B1 EP04796177.6A EP04796177A EP1675506B1 EP 1675506 B1 EP1675506 B1 EP 1675506B1 EP 04796177 A EP04796177 A EP 04796177A EP 1675506 B1 EP1675506 B1 EP 1675506B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- antenna element
- antenna
- extravasation
- sensor
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012530 fluid Substances 0.000 title claims description 46
- 230000035945 sensitivity Effects 0.000 claims description 35
- 239000000853 adhesive Substances 0.000 claims description 27
- 230000001070 adhesive effect Effects 0.000 claims description 27
- 230000007246 mechanism Effects 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 19
- 230000005540 biological transmission Effects 0.000 claims description 17
- 239000000758 substrate Substances 0.000 claims description 11
- 230000008859 change Effects 0.000 claims description 5
- 230000000712 assembly Effects 0.000 claims description 4
- 238000000429 assembly Methods 0.000 claims description 4
- 206010015866 Extravasation Diseases 0.000 description 80
- 230000036251 extravasation Effects 0.000 description 80
- 210000001519 tissue Anatomy 0.000 description 43
- 238000001514 detection method Methods 0.000 description 26
- 238000002347 injection Methods 0.000 description 21
- 239000007924 injection Substances 0.000 description 21
- 238000000034 method Methods 0.000 description 21
- 238000002559 palpation Methods 0.000 description 12
- 230000000007 visual effect Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 239000002872 contrast media Substances 0.000 description 8
- 230000035699 permeability Effects 0.000 description 8
- 206010018852 Haematoma Diseases 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 230000002159 abnormal effect Effects 0.000 description 5
- 239000002390 adhesive tape Substances 0.000 description 5
- 238000007920 subcutaneous administration Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 206010019196 Head injury Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229910010293 ceramic material Inorganic materials 0.000 description 4
- 229910052802 copper Inorganic materials 0.000 description 4
- 239000010949 copper Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 241000251468 Actinopterygii Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000002667 Subdural Hematoma Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000004020 conductor Substances 0.000 description 3
- 239000013039 cover film Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010048962 Brain oedema Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010037423 Pulmonary oedema Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000002583 angiography Methods 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 208000006752 brain edema Diseases 0.000 description 2
- 238000002591 computed tomography Methods 0.000 description 2
- 238000013170 computed tomography imaging Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000005294 ferromagnetic effect Effects 0.000 description 2
- 239000003302 ferromagnetic material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000002595 magnetic resonance imaging Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 208000005333 pulmonary edema Diseases 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000012144 step-by-step procedure Methods 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- 210000000707 wrist Anatomy 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 206010015769 Extradural haematoma Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000002616 MRI contrast agent Substances 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000031809 Subdural Acute Hematoma Diseases 0.000 description 1
- 208000037132 Subdural Chronic Hematoma Diseases 0.000 description 1
- 239000002313 adhesive film Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229940044683 chemotherapy drug Drugs 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 229940039231 contrast media Drugs 0.000 description 1
- 239000011889 copper foil Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000001723 extracellular space Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000002648 laminated material Substances 0.000 description 1
- 210000004324 lymphatic system Anatomy 0.000 description 1
- 230000005291 magnetic effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000013528 metallic particle Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000003200 peritoneal cavity Anatomy 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000008288 physiological mechanism Effects 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 238000002600 positron emission tomography Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 210000003625 skull Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008320 venous blood flow Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/0507—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves using microwaves or terahertz waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/053—Measuring electrical impedance or conductance of a portion of the body
- A61B5/0537—Measuring body composition by impedance, e.g. tissue hydration or fat content
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
- A61B5/4875—Hydration status, fluid retention of the body
- A61B5/4878—Evaluating oedema
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
- A61B5/6833—Adhesive patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
- A61M5/16836—Monitoring, detecting, signalling or eliminating infusion flow anomalies by sensing tissue properties at the infusion site, e.g. for detecting infiltration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/04—Arrangements of multiple sensors of the same type
- A61B2562/046—Arrangements of multiple sensors of the same type in a matrix array
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/35—Communication
- A61M2205/3507—Communication with implanted devices, e.g. external control
- A61M2205/3523—Communication with implanted devices, e.g. external control using telemetric means
Definitions
- the present invention relates generally to the detection of fluid and/or other material in tissue, and especially, to a system for detecting changes in the level of fluid in tissue.
- the system of the present invention detects if fluid level has increased or has otherwise become abnormal.
- edema is an abnormal accumulation of watery fluid in the intercellular spaces of connective tissue. Edematous tissues are swollen and, when punctured, secrete a thin incoagulable fluid. Edema is most frequently a symptom of disease rather than a disease in itself, and it may have a number of causes, most of which can be traced back to gross variations in the physiological mechanisms that normally maintain a constant water balance in the cells, tissues, and blood. Among the causes may be diseases of the kidneys, heart, veins, or lymphatic system; malnutrition; or allergic reactions.
- Hematomas can, for example,) occur beneath the outermost of three membranes that cover the brain (meninges) as a result of a head injury.
- An acute subdural hematoma occurs soon after a severe head injury.
- a chronic subdural hematoma is a complication that may develop weeks after a head injury. Such a head injury may have been so minor that the patient does not remember it.
- An epidural hematoma is a traumatic accumulation of blood between the inner table of the skull and the stripped-off dural membrane. The inciting event often is a focused blow to the head. It is often difficult to detect hematomas, particularly when the hematoma occurs well after the time of an injury.
- Extravasation or infiltration is the accidental infusion or leakage of an injection fluid such as a contrast medium or a therapeutic agent into tissue surrounding a blood vessel rather than into the blood vessel itself.
- Extravasation can be caused, for example, by rupture or dissection of fragile vasculature, valve disease, inappropriate needle placement, or patient movement resulting in the infusing needle being pulled from the intended vessel or causing the needle to be pushed through the wall of the vessel.
- High injection pressures and/or rates of some modern procedures can increase the risk of extravasation.
- contrast injection flow rates can be in the range of 0.1 to 10 ml/s.
- Extravasation can cause serious injury to patients.
- certain injection fluids such as contrast media or chemotherapy drugs can be toxic to tissue. It is, therefore, very important when performing fluid injections to detect extravasation as soon as possible and discontinue the injection upon detection.
- extravasation detection techniques Two simple and very useful techniques for detecting extravasation are palpation of the patient in the vicinity of the injection site and simple visual observation of the vicinity of the injection site by a trained health care provider.
- the health care provider manually senses swelling of tissue near the injection site resulting from extravasation.
- visual observation it is also sometimes possible to observe directly any swelling of the skin in the vicinity of an injection site resulting from extravasation.
- mercury strain gauge plethysmographs measure the volume change resulting from venous blood flow in a cross sectional area of a limb of a patient.
- Air cuff or pulse volume recorder plethysmographs measure the changes in pressure within a recording cuff.
- Such plethysmographs can be cumbersome to operate and/or insensitive to small changes in volume.
- Impedance plethysmographs use low-frequency electromagnetic energy transmitted via galvanic contact with the skin to measure changes in the electrical impedance in a defined tissue volume of a limb. Detection of extravasation via impedance changes is disclosed, for example, in U. S. Patent Nos. 5,964, 703 and 5,947, 910 . In this method, an impedance change of a certain level relative to a baseline measurement in the vicinity of the injection site is interpreted as being an extravasation. A change in impedance occurs during extravasation because injection fluid in the tissue of the patient changes both the volume and the electrical impedance properties of the tissue.
- Use of electrodes in impedance plethysmographs can, however, result in instabilities. For example, maintaining suitable electrical (ohmic or galvanic) contact between the electrodes of impedance plethysmographs and the skin of the patient is often very difficult.
- Photo-plethysmographs measure the optical scattering properties of capillary blood to detect the presence of extravasated fluids in tissue.
- An example of a photoplethysmograph is described in U. S. Patent 4, 877, 034 . Because light is heavily absorbed in tissue, however, the sensitivity of photo-plethysmographs is generally limited to the top 1/4 inch of tissue. Many extravasations, however, occur deeper than 1/4 inch. Moreover, the injection medium may flow into interstitial spaces remote from the photoplethysmograph sensors and go undetected.
- U. S. Patent 4,647, 281 discloses subcutaneous temperature sensing of extravasation to trigger an alarm.
- an antenna and a microwave radiometer instantaneously measure the temperature of the subcutaneous tissue at the site where fluid is injected by measuring microwave radiation emitted naturally from the body.
- An algorithm periodically determines the temperature difference between tissue and injected fluid, and compares the difference to a fixed threshold.
- An alarm processor uses the comparison to determine an alarm condition.
- U. S. Patent 5,334, 141 discloses a microwave extravasation detection system employing a reusable microwave antenna and a disposable attachment element for releasably securing the microwave antenna to a patient's skin over an injection site.
- the attachment element holds the antenna in intimate contact with the patient's skin to optimize microwave transfer therebetween, while shielding the antenna from environmental noise signals.
- U. S. Patent 5,954, 668 also discloses use of a microwave antenna to sense temperature of tissue to detect extravasation. Although measurement of temperature changes and emissivity using microwave energy can result in instantaneous detection, temperature differences are often too small for practical measurement.
- U. S. Patent 4, 488, 559 discloses detection of pulmonary edema via transmitting electromagnetic energy through a transmission line coupled to tissue.
- U. S. Patent 4,690, 149 discloses detection of brain edema via impedance changes detected by a sensor.
- a proposed method of detection of brain edema is also disclosed in U. S. Patent 6,233, 479 , in which a measured signal from a microwave antenna is compared to a stored characteristic edema signal.
- Microwave energy has also been used for the detection of tumors in living tissue as described in U. S. Patent 6,061, 589 .
- U. S. Patent 6,061, 589 disclosed transmission of electromagnetic energy into the body (breast tissue) using a microwave antenna in and a resultant signal is measured.
- U. S. Patent 6,061, 589 describes a microwave antenna to detect incipient tumors in accordance with differences in relative dielectric characteristics. Electromagnetic energy in the microwave frequency range is applied to a discrete volume in the tissue and scattered signal returns are collected. The irradiated location is shifted or changed in a predetermined scanning pattern. The returned signals are processed to detect anomalies indicative of the present of a tumor.
- Microwave energy has also been used as in non-invasive tomographic spectroscopy imaging. See U. S. Patent Nos. 6,332, 087 and 6,026, 173 . Microwave energy has further been used to measure the fat content in nonliving organic tissue.
- M. Kent, "Hand Held Fat/Water Determination", (1993), available at www.distell.conz/products/papers/paper2.htm discloses a microstrip sensor for such a determination.
- the fat content of pelagic and other fatty species of fish is proportion to water content.
- the dielectric properties of the fish depend on the water content. In the device of Kent, changes in transmission properties of the fish were calibrated against water content.
- a sensor device having a u-shaped housing including arrays of transmitting and receiving antennas for detection of fluid changes within tissue is disclosed by US 2003/0036674 A1 .
- the area of highest detection sensitivity is located within in an opening formed by the u-shaped housing.
- the sensor device further includes an RF cable assembly for each of the antenna elements.
- Each of the RF cable assemblies includes at one end thereof a connector. At the other end thereof, the RF cable assembly is electrically connected to the antenna element corresponding thereto.
- the sensor device can additionally or alternatively include at least one flexible circuit board assembly for transmission of energy to and from the antenna elements.
- the flexible circuit board can include at least one splitter such that electromagnetic energy can be transmitted to at least two of the plurality of antenna elements using a single transmission trace within the flexible circuit board.
- the flexible circuit board can include at least one combiner such that electromagnetic energy can be received from at least two of the plurality of antenna elements and carried by a single transmission trace within the flexible circuit board.
- the sensor device can further include an attachment mechanism to operably attach the sensor device to the tissue of the body.
- the attachment mechanism can include an adhesive portion defining a cutout region generally coextensive with the opening of the housing.
- the adhesive portion has one side thereof coated with a first adhesive adapted to removably attach to the tissue and an opposite side thereof coated with a second adhesive adapted to attach to a bottom surface of the housing.
- the attachment mechanism can further include a release band affixed to a perimeter of the adhesive portion.
- the first adhesive is adapted to facilitate removal of the attachment mechanism from the patient.
- the first adhesive can provide less adhesion than the second adhesive.
- the system of the present invention is generally applicable to the sensing any fluid within body tissue (whether a body fluid or an introduced fluid), the present invention is primarily described herein with reference to the representative example of extravasation of a fluid intended to be injected into a vascular structure.
- elevated, abnormal or changing levels of generally any fluid can be detected using the sensors, systems and methods of the present invention.
- Detection of body fluids in the present invention includes, but is not limited to, the detection of fluid changes as a result of edema, hematoma, ruptured bowel and colostomy tubing leakage into the peritoneal cavity.
- Introduced or foreign fluid detectible in the present invention include fluid introduced via generally any technique known in the medical arts including, but not limited to, injection, infusion and IV drip. As described above, changes in complex permittivity and permeability as a result of changing fluid levels in tissue are detected by application of electromagnetic energy to the tissue and detection of a resultant signal.
- Complex permittivity and permeability govern how an-electromagnetic wave will propagate through a substance.
- Complex permittivity typically has the greatest effect since it varies significantly between tissue types and fluids of interest.
- the complex permeability of various tissues and many fluids of interest is approximately that of a vacuum, reducing the effect of this parameter.
- Some fluids, however, such as MRI contrast agents may have an appreciable complex permeability difference from tissue.
- blood contains small amounts of iron, the permeability value for any significant volume of blood is typically insignificant.
- ⁇ is the imaginary component of the complex value and is often referred to as the "loss factor.”
- the ratio of ( ⁇ "/ ⁇ ') is known as the "loss tangent.”
- the complex permittivity (and sometimes permeability) of certain substances differ from the body tissue at certain frequencies. In the present invention, such differences in permittivity and/or permeability are used for the detection and level monitoring of certain fluids and substances in biological tissue.
- Electromagnetic energy in the frequency range set forth above has been found to transmit through the skin and to transmit or propagate well within, for example, fat. Good transmission through the fat layer is beneficial for detection of extravasation as many extravasations occur in the fat layer. The sensitivity to extravasation of the systems, devices and methods of the present invention is thus increased as compared, for example, to impedance plethysmography.
- FIG. 1A-1 E illustrate multiple views of one embodiment of an extravasation sensor 10 of the present invention.
- Extravasation sensor 10 includes a housing 20, a plurality of antenna or sensor elements 60a, 60b 60c and 60d, and the RF cable assemblies 100 associated therewith.
- Each of coaxial cables 100 includes a subminiature coaxial connector (SMA connector) 110.
- SMA connector subminiature coaxial connector
- the housing 20 can, for example, be fabricated from a base material, such as urethane and/or silicone material.
- a ferromagnetic and/or other material suitable to absorb leakage of electromagnetic energy can be mixed into the base material.
- a carbonyl iron powder such as the EW grade carbonyl iron powder produced by the BASF Corporation, of Mount Olive, New Jersey, is suitable for this purpose.
- the ferromagnetic powder is mixed into the housing base material at least around the antenna elements and cables.
- a ferromagnetic material with appreciable permeability e. g., > 1
- leakage could potentially cause artifacts to be induced within the signals conveyed from the antenna elements 30 as a result of, for example, palpation of the skin in the area of the extravasation sensor 10 or as a result of other movement of the sensor 10.
- artifacts could also decrease the sensitivity of the sensor 10 to the presence of subcutaneous fluid. It is apparent that one can also mix the ferromagnetic material into a different base material (for example, a base material that will form a more rigid housing).
- housing 20 of the extravasation sensor 10 defines an opening 24 between the antenna elements 60a-d. Opening 24 provides both visual and tactile (palpation) access to the site of interest where subcutaneous fluid will likely accumulate should extravasation occur. Opening 24 thus provides the operator with the option of checking for or confirming the presence of fluid merely by looking at or palpating the skin through opening 24 in housing 20.
- Housing 20 also includes segments 30 and 30a that bridge the gap between seatings 40 (positioned at intersections 50 between connected segments 30 and 30a) in which antenna elements 60a-d are seated.
- Bridge segments 30 and 30a are, for example, low in profile to provide an operator access through opening 24 to the site of interest for the purpose of palpation. Nurses or technologists often position their hand in such a manner that low-profile bridge segments 30 and 30a (particularly those bridge segments 30a on the sides of sensor 10) allow improved ability to palpate the site of interest to check for extravasation.
- side bridge segments 30a can be curved outwardly away from the center of the palpation area to allow increased accessibility.
- antenna elements 60a-d (each of which is generally identical in structure), in several embodiments of the present invention, include an active antenna or resonant structure 62 surrounded by a substrate 64 such as a ceramic material (for example, MgCaTiO 2 ).
- Resonant structures 62 are, for example, adapted to transmit and receive electromagnetic energy in the frequency ranges set forth above.
- the substrate material can, for example, have a moderate to high dielectric constant (for example, in the range of approximately 5 to approximately 100 or in the range of approximately 50 to approximately 80) or high permittivity and low loss.
- the impedance of substrate 64 is preferably similar to that of the surface of the tissue to be studied.
- antenna elements 60a-d of the present invention did not include a superstrate material.
- the antenna elements such as shown in Figure 7D of each of those published U. S. patent applications were positioned atop or otherwise formed within a substrate and shielded from direct contact with the skin by use of a superstrate.
- antenna elements 60a-d With forming antenna elements 60a-d without a superstrate, antenna element 60a-d becomes electromagnetically loaded when adjacent to human tissue on which extravasation sensor 10 is positioned. This electromagnetic loading increases the bandwidth of extravasation sensor 10, which increases its ability to detect subcutaneous pools of various shapes and sizes.
- Microstrip antennae 60a through 60d used in several studies of the present invention were fabricated from a ceramic laminate material coated with thin layers of copper on the front and back thereof.
- a ceramic laminate material coated with thin layers of copper on the front and back thereof.
- Such a material is, for example, available from Rogers Corporation of Chandler, Arizona under the product name RT/duroid® 6010LM.
- Such microwave laminates are ceramic-PTFE composites designed for electronic and microwave circuit applications requiring a relatively high dielectric constant.
- RT/duroid 6010LM laminate has a dielectric constant of approximately 10.2.
- the laminate was approximately 2.5 mm thick and was supplied with both sides thereof clad with 1/4 to 2 oz./ft. 2 (8 to 70 ⁇ m) electrodeposited copper foil.
- antennae or microstrip antennae 60a-d of the present invention
- some of the copper material was etched from the top of the laminate to form generally planar antenna active element or resonant structure 62, thereby forming a margin between the outer edge of resonant structure 62 and the outer edge of substrate 64.
- the copper on the bottom side of the laminate formed ground plane 66 of antenna 62a-d.
- Side shielding 68 of a conductive material can be provided to, for example, improve tissue coupling and prevent stray energy.
- Each antenna element 60a through 60d can also include a conductive front lip 67 on the surface of the ceramic material to provide additional shielding. Coupled with the protection provided by the side shielding 68, forward conductive lip 67 for each antenna elements 60a-d serves to further decrease the leakage of stray electromagnetic energy.
- conductive lip 67 was fabricated from a conductive material such as copper having a thickness of approximately 0.010 inches.
- sensor 10 includes two antenna sets or pairs 70a and 70b.
- First antenna pair 70a includes first transmitting antenna element 60a and first receiving antenna element 60b.
- Second antenna pair 70b includes second transmitting antenna element 60c and second receiving antenna element 60d.
- the transmitting and receiving antenna elements of each of first antenna pair 70a and second antenna pair 70b are held in spaced connection by bridging segments 30.
- the length of bridging segments 30, and thus the space between the transmitting and receiving antenna elements can be used to adjust the sensitivity of the antenna pair to fluid changes in the high sensitivity zone of the sensor (see, for example, Figure 2 and the discussion thereof below) located between the transmitting antenna and the receiving antenna of the antenna pair.
- increasing the distance between the transmitting antenna and the receiving antenna increases the volume of tissue encompassed by the high sensitivity zone, but also increases the minimum volume of fluid change that can be detected.
- Figure 2 illustrates a schematic structural layout for extravasation sensor 10 of the present invention, in which four antenna elements 60a through 60d are separated to form a first high sensitivity zone 80a between antenna elements 60a and 60b and a second high sensitivity zone between antenna elements 60c and 60d. Between high sensitivity zones 80a and 80b is a region or zone 84 of lower or reduce sensitivity.
- the size of the reduced sensitivity zone 84 (and the sensitivity therein) is determined by the length of side bridging segments 30a which operatively connect and space first antenna pair 70a and second antenna pair 70b.
- the spacing between antenna pairs 70a and 70b effectively increases the sensing range of extravasation sensor 10.
- lower sensitivity to small volumes of subcutaneous fluid in reduced sensitivity zone 84 between antenna pairs 70a and 70b is achieved by spacing antenna pairs 70a and 70b.
- High sensitivity zones 80a and 80b are "primary" areas in which fluid build up can be detected with highest sensitivity.
- the formation of intermediate, reduced sensitivity zone 84 allows a small, clinically insignificant amount of fluid (e.
- sensor 10 can be positioned so that the tip of the injection catheter is placed within reduced sensitivity zone 84 (for example, positioned generally centrally within reduced sensitivity zone 84 or within open area 24).
- reduced sensitivity zone 84 allows small, clinically insignificant, extravasation (blood and/or contrast agent) volumes to accumulate while significantly reducing the probability of a false positive alarm. Indeed, in several clinical studies of the present invention, false positive alarms were maintained below 0.1 % while a positive extravasation detection rate in excess of 95% was achieved.
- reduced sensitivity zone 84 is located between high sensitivity zones or sensing areas 80a and 80b. Increased fluid levels in low sensitivity region 84 can cause tissue distortion in one or both of high sensitivity zones 80a and 80b, and indirectly cause some level of sensor response. Because of such effective overlap of high sensitivity zones 80a and 80b and intermediate, reduced sensitivity zone 84, the overall fluid volume sensing range of sensor 10 is increased significantly.
- housing 20 In addition to maintaining a predetermined, desired spacing between the antenna elements of each antenna element pair and a predetermined, desired spacing between the antenna element pairs, housing 20 also maintains a desired relative orientation between the antenna elements of each antenna element pair and between the antenna element pairs. Also, housing 20 assists in assuring that each of antenna elements 60a-d is generally coplanar when sensor device 10 is in operative connection with a patient's skin.
- FIG. 3 illustrates an embodiment, which is not part of the invention, and which uses a flexible circuit board (also referred to as a "RF flex circuit board”) to create a unique thin, "flexible strip” or flexible circuit transmission system 200 that can be used to carry and distribute the electromagnetic (for example, microwave) signals being transmitted from and received by extravasation sensor 300.
- Sensor 300 includes antenna elements 360a-d which operate in a manner as described above in connection with antenna elements 60a-d.
- Flexible strip transmission system 200 includes transmission lines or traces 210.
- the flexible strip transmission system 200 is provided with "side vias" 220 which (in connection with conductive layers laminated on the major surfaces of the flexible strip) complete a shielded, full coaxial structure for use in carrying microwave signals to and from antenna elements 360a-d of sensor 300.
- top and bottom conductive layers of flexible strip transmission system 200 serve as ground planes, while vias between those layers are used to provide side shielding.
- traces 210 can, for example, include splitting and combining geometries 212 to split the energy between multiple transmitting antenna elements such as antenna elements 260a and 260c and to combine energy from multiple receiving antenna elements such as antenna elements 260b and 260d if desired. This splitting and combining allows the use of fewer cables when connecting sensor 300 to processing circuitry. Flex circuit boards and other materials suitable for use at microwave frequencies are commercially available from, for example, DuPont and the Advanced Circuit Materials Division of Rogers Corporation, of Chandler, Arizona.
- a further advantage of the use of flex circuit board in connection with an energy transmission system of the sensors of the present invention is that a low-profile connection to the antennas elements can be achieved.
- Use of coaxial cables which are soldered to the antennas elements of the present invention can require a sizeable bending radius, creating a higher profile connection.
- RF flex circuit includes an RF vertical transition including a center signal via surrounded by ground/reference vias completing a coaxial structure to transmit/receive microwave energy to and from the antennas elements.
- the antenna elements can, for example, be wave soldered in an automated process directly to the thin RF flex circuit without use of additional connectors or cables, achieving a low-profile connection.
- Figure 4 illustrates a step-by-step procedure for using an attachment mechanism 400 of the present invention to attach an extravasation sensor 450 of the present invention to the skin of a patient.
- attachment mechanism 400 includes a double-sided adhesive portion 410 and a release band 420 (which preferably includes no adhesive) around the perimeter of adhesive portion 410.
- adhesive portion 410 defines a cutout region 430. Cutout region 430 can be shaped in the shape of an arrow (pointing, for example, in the direction of contrast medium flow) or other shape to indicate a preferred orientation for attachment.
- double-sided adhesive portion 410 is designed to attach to the skin of the patient over the site or region of interest (typically centralized on the tip of the catheter), and the opposite side is designed to permit extravasation sensor 450 to be affixed thereto.
- cutout region 430 of adhesive portion 420 and an opening 470 of extravasation sensor 450 are generally coextensive, thereby allowing the operator visual and tactile (palpation) access to the site of interest.
- a first step an operator removes a first cover film or layer 412 from the side of double-sided adhesive portion 410 including the adhesive adapted to attach to the patient's skin.
- attachment mechanism 400 is attached to the patient skin with the arrow of cutout portion 430 pointing in the direction of the contrast medium flow.
- a second cover film or layer 414 is removed from the side of double-sided adhesive portion 410 including the adhesive adapted to attach sensor 450 to attachment mechanism 400.
- sensor 450 is attached to the attachment mechanism 400 so that open area 470 of sensor 450 is in general alignment with cutout region 430.
- the sensing module is armed.
- release band 420 of attachment mechanism 400 enables the operator to pull attachment mechanism 400 off the skin after use of extravasation sensor 450 is complete.
- the color, material or texture of adhesive portion 410 and release band 420 can be different. This difference facilitates the positioning and secure attachment of extravasation sensor 450.
- Each side of attachment mechanism 400 can have a different level of adhesion (i.e., aggressiveness of adhesive) which facilitates the tailoring of the adhesion to the skin side which may be less than that of the sensor side.
- This tape is fabricated from a hypoallergenic polyethylene material. Whatever double-sided adhesive tape or film is used, the double-sided adhesive tape preferably maintains sufficient contact with the skin and (upon proper use) provides resistance to wrinkling and formation of air pockets upon placement.
- the double-sided adhesive tape material preferably has a low electromagnetic loss factor (that is, in the sensor's operating frequency range). Such properties allow the electromagnetic energy (for example, microwaves) to penetrate the adhesive tape effectively. Most adhesive tapes possess these characteristics. Tapes that contain metallic particles or other conductive materials, however, may not be suitable for use in the attachment mechanisms of the present invention.
- the tape can, however, contain, for example, a material such as a ceramic material that yields a thin structure with low electromagnetic loss and an impedance that matches the surface tissue. This embodiment can provide better coupling of the microwave energy between the antennas and the tissue to increase detection sensitivity while decreasing leaked energy and thereby decreasing any palpation/motion artifact.
- the inner or patient side cover film 412 is the removed and the attachment mechanism/sensor assembly is placed against the skin, briefly applying pressure.
- opening 470 for palpation in the housing of extravasation sensor 400 as well as the cutout region of the attachment mechanism can be formed to indicate the direction to which the sensor should be placed (e.g., arrow shaped). This shape of opening 470 also helps the operator to align extravasation sensor 450 and attachment mechanism 400 for optimal attachment to a patient's skin, which is important for integrity of the signals detected and conveyed by extravasation sensor 400.
- Extravasation sensor 450 and other extravasation sensors of the present invention can also be equipped with one or more user interfaces or indicator.
- Figures 6A and 6B respectively, illustrate that a light pipe 480 or other visual indicators, such as light- emitting diodes 580 (LEDs) on sensor 500, can be incorporated into the extravasation sensors of the present invention to provide, for example, a visual indication of extravasation. Additional or alternatively, other types of indicators such as audible indicators or tactile indicators can be provided.
- a light pipe 480 is incorporated into the RF cable assembly that interconnects the extravasation sensor and its associated base/control unit so that the entire cable or a portion thereof lights to indicate a positive extravasation state.
- a light pipe can also pass through the cabling to light an indicator on the housing of the sensor.
- a plurality of indicator lights 580 are provided.
- a user input button for functions such as "arming" or" baselining" the overall system can be implemented at the extravasation sensor of the present invention.
- indicator 580 is also a user input button.
- An audible, tactile and/or visual alarm can also be integrated within the housing of the sensor.
- An indicator device such as indicator light 480'can alternatively or additionally be mounted to or otherwise integrated into a remote display or controller unit for the injector system, as, for example, illustrated in Figure 5 in the context of a CT imaging suite.
- a remote display or control unit is typically located in the control room of a CT suite rather than in the scanner room where the injector and extravasation sensor will be sited.
- Figure 7 illustrates a system 700 for wirelessly transmitting a signal indicative of extravasation from an extravasation sensor 800 outfitted with a transmitter 710 (for example, an RF transmitter) to a remote receiver 720.
- a wireless system 700 can be implemented with any extravasation sensor of the present invention.
- wireless system 700 includes a short RF cable 730 connecting sensor 800 to transmitter 710.
- extravasation sensor 800 can be attached to, for example, the upper arm about the site of the injection and transmitter 710 can be strapped or otherwise attached near or directly to the wrist. If extravasation sensor 800 is attached to the back of the hand or wrist, RF transmitter 710 can then be strapped to the upper arm much like a sports radio.
- Short RF cable 730 interconnects the two components as described above, and can be either a distinct component or emanate from the housing of sensor 800. Short RF cable 730 in this configuration can improve performance and decrease the potential of motion artifacts and other complications that may be associated with certain longer cables.
- sensor 800 includes a palpation opening 840 and indicator lights 880 which operate as described above.
- PET positron emission tomography
- MRI magnetic resonance imaging
- MRA magnetic resonance angiography
- ultrasound procedures as well as a wide variety of therapeutic and other procedures.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Vascular Medicine (AREA)
- Physiology (AREA)
- Computer Networks & Wireless Communication (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Immunology (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Arrangements For Transmission Of Measured Signals (AREA)
Claims (9)
- Système comprenant un capteur destiné à détecter une modification dans le niveau d'un fluide à l'intérieur du tissu d'un corps, ainsi qu'une unité de commande associée reliée au capteur, le capteur comprenant :un logement (20) comportant une pluralité de segments (30, 30a) formant pont, les segments formant pont (30, 30a) comprenant des segments de pontage (30) et des segments d'espacement (30a), les segments formant pont se raccordant au niveau d'intersections (50) et étant agencés pour circonscrire une ouverture (24) définie par le logement, etquatre et seulement quatre éléments d'antenne (60a à d), au moins partiellement appuyés dans le logement au niveau des intersections des segments formant pont (30a, 30b), les éléments antenne (60a à d) étant agencés en une forme rectangulaire et les coins de la forme rectangulaire étant formés par les éléments d'antenne (60a à d), chaque élément d'antenne comprenant une antenne globalement plane montée sur un matériau formant substrat (64) au niveau de la base de l'antenne plane, la surface externe de l'antenne plane étant opposée au substrat, chaque élément d'antenne comprenant de plus un écran électrique entourant le substrat,dans lequel les éléments d'antenne (60a à d) comprennent une première paire d'éléments d'antenne (70a) et une seconde paire d'éléments d'antenne (70b), la première paire d'éléments d'antenne (70a) comprenant un premier élément d'antenne d'émission (60a) et un premier élément d'antenne de réception (60b), le premier élément d'antenne d'émission (60a) étant espacé du premier élément d'antenne de réception (60b) et relié à celui-ci par l'intermédiaire d'un premier segment de pontage (30),la seconde paire d'éléments d'antenne comprenant un second élément d'antenne d'émission (60c) et un second élément d'antenne de réception (60d), le second élément d'antenne d'émission (60c) étant espacé du second élément d'antenne de réception (60d) et relié à celui-ci par l'intermédiaire d'un second segment de pontage (30),dans lequel l'unité de commande est conçue pour émettre un signal vers la première et la seconde antenne d'émission (60a, 60c), et elle est conçue pour recevoir un signal provenant de la première et de la seconde antenne de réception (60b, 60d),dans lequel une première zone de plus grande sensibilité (80a) est définie par la surface comprise entre le premier élément d'antenne d'émission (60a) et le premier élément d'antenne de réception (60b), et une seconde zone de plus grande sensibilité (80b) est définie par la surface comprise entre le second élément d'antenne d'émission (60c) et le second élément d'antenne de réception (60d),dans lequel la première paire d'éléments d'antenne (70a) et la seconde paire d'éléments d'antenne (70b) sont placées pour être éloignées d'un premier segment d'espacement (30a) et d'un second segment d'espacement (30a) de telle sorte que soit définie une zone ouverte (24) par la première paire d'éléments d'antenne (70a), la seconde paire d'éléments d'antenne (70b), le premier segment d'espacement (30a) et le second segment d'espacement (30a), le premier segment d'espacement (30a) et le second segment d'espacement (30a) créant un espace entre la première paire d'éléments d'antenne (70a) et la seconde paire d'éléments d'antenne (70b) afin de créer une zone de sensibilité réduite (84) entre la première paire d'éléments d'antenne (70a) et la seconde paire d'éléments d'antenne (70b),et dans lequel la distance entre les première et seconde paires d'antennes (70a, 70b) est supérieure à la distance entre le premier élément d'antenne d'émission (60a) et le premier élément d'antenne de réception (60b), et supérieure à la distance entre le second élément d'antenne d'émission (60c) et le second élément d'antenne de réception (60d).
- Système selon la revendication 1, dans lequel le capteur comprend en outre un assemblage de câbles HF (100) pour chacun des éléments d'antenne (60a à d), chacun des ensembles de câbles HF comprenant à l'une de ses extrémités un connecteur (110) et étant relié électriquement à l'élément d'antenne qui lui correspond à son autre extrémité.
- Système selon la revendication 1 ou 2, dans lequel le capteur comprend en outre au moins une carte à circuit imprimé souple (200) pour permettre la transmission d'énergie depuis et vers les éléments d'antenne (60a à d).
- Système selon la revendication 3, dans lequel la carte à circuit imprimé souple (200) comprend au moins un séparateur (212) de telle sorte que l'énergie électromagnétique puisse être transmise vers au moins deux de la pluralité d'éléments d'antenne en utilisant une unique piste de transmission (210) dans la carte à circuit imprimé souple.
- Système selon la revendication 3 ou 4, dans lequel la carte à circuit imprimé souple comprend au moins un circuit de combinaison (212) de telle sorte que l'énergie électromagnétique puisse être reçue depuis au moins deux de la pluralité d'éléments d'antenne et soit transportée par une unique piste de transmission (210) dans la carte à circuit imprimé souple.
- Système selon l'une quelconque des revendications 1 à 5, dans lequel le capteur comprend en outre un mécanisme de fixation (400) destiné à fixer fonctionnellement le capteur (450) au tissu du corps, le mécanisme de fixation comprenant : une partie adhésive (410) définissant une région de découpe (430) globalement coextensive avec l'ouverture du logement, la partie adhésive présentant un côté revêtu d'un premier adhésif conçu pour se fixer au tissu tout en étant amovible, et le côté opposé de celle-ci comportant un second adhésif conçu pour se fixer à la surface inférieure du logement.
- Système selon la revendication 6, dans lequel le mécanisme de fixation (400) comprend en outre une bande de libération (420) fixée au périmètre de la partie adhésive (410).
- Système selon la revendication 6 ou 7, dans lequel le premier adhésif procure moins d'adhérence que le second adhésif.
- Système selon l'une quelconque des revendications 1 à 8, dans lequel l'écran électrique comprend une section arrière (66) contiguë au côté arrière du substrat, des écrans latéraux (68) entourant les flancs du substrat et une section avant (67) contiguë au côté avant du substrat et s'étendant vers l'intérieur depuis les écrans latéraux, une marge étant maintenue contre l'antenne plane et la section avant.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12005361.6A EP2526857B1 (fr) | 2003-10-24 | 2004-10-25 | Système et méthode pour détecter des changements de fluides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US51435503P | 2003-10-24 | 2003-10-24 | |
PCT/US2004/035135 WO2005043100A2 (fr) | 2003-10-24 | 2004-10-25 | Systemes pour detecter des variations fluidiques et dispositifs de detection correspondants |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12005361.6A Division-Into EP2526857B1 (fr) | 2003-10-24 | 2004-10-25 | Système et méthode pour détecter des changements de fluides |
EP12005361.6A Division EP2526857B1 (fr) | 2003-10-24 | 2004-10-25 | Système et méthode pour détecter des changements de fluides |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1675506A2 EP1675506A2 (fr) | 2006-07-05 |
EP1675506A4 EP1675506A4 (fr) | 2010-06-23 |
EP1675506B1 true EP1675506B1 (fr) | 2015-09-16 |
Family
ID=34549328
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12005361.6A Not-in-force EP2526857B1 (fr) | 2003-10-24 | 2004-10-25 | Système et méthode pour détecter des changements de fluides |
EP04796177.6A Active EP1675506B1 (fr) | 2003-10-24 | 2004-10-25 | Systeme pour detecter des variations fluidiques |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP12005361.6A Not-in-force EP2526857B1 (fr) | 2003-10-24 | 2004-10-25 | Système et méthode pour détecter des changements de fluides |
Country Status (5)
Country | Link |
---|---|
US (2) | US8295920B2 (fr) |
EP (2) | EP2526857B1 (fr) |
JP (1) | JP4511549B2 (fr) |
CN (1) | CN100482151C (fr) |
WO (1) | WO2005043100A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9289550B1 (en) | 2001-02-06 | 2016-03-22 | Bayer Healthcare Llc | Apparatus and method for detecting fluid extravasation |
US11883144B2 (en) | 2011-09-02 | 2024-01-30 | Battelle Memorial Institute | Integrated extravasation and infiltration detection device on a RF isolated flexible substrate with fluid guide to detect fluid changes via signal comparison |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060211970A1 (en) * | 2005-03-16 | 2006-09-21 | Sciulli Frank J | Releasable application systems and releasable medical device systems |
WO2006127355A2 (fr) | 2005-05-20 | 2006-11-30 | Dow Global Technologies Inc. | Controle de l'observance d'un medicament oral a l'aide d'etiquettes d'identification par radiofrequence |
WO2007124298A2 (fr) * | 2006-04-19 | 2007-11-01 | Acist Medical Systems, Inc. | dispositif de détection d'extravasation |
US7674244B2 (en) | 2006-05-23 | 2010-03-09 | Medrad, Inc. | Devices, systems and methods for detecting increase fluid levels in tissue |
US20110160549A1 (en) | 2007-09-05 | 2011-06-30 | Saroka Amir | Method, system and apparatus for using electromagnetic radiation for monitoring a tissue of a user |
US8989837B2 (en) | 2009-12-01 | 2015-03-24 | Kyma Medical Technologies Ltd. | Methods and systems for determining fluid content of tissue |
US10667715B2 (en) * | 2008-08-20 | 2020-06-02 | Sensible Medical Innovations Ltd. | Methods and devices of cardiac tissue monitoring and analysis |
ES2637021T3 (es) | 2009-03-04 | 2017-10-10 | Sensible Medical Innovations Ltd. | Sistema para monitorizar tejidos intracorporales |
US9462964B2 (en) | 2011-09-23 | 2016-10-11 | Orthosensor Inc | Small form factor muscular-skeletal parameter measurement system |
US8707782B2 (en) | 2009-06-30 | 2014-04-29 | Orthosensor Inc | Prosthetic component for monitoring synovial fluid and method |
US20100331733A1 (en) | 2009-06-30 | 2010-12-30 | Orthosensor | Sensing device and method for an orthopedic joint |
US9839390B2 (en) | 2009-06-30 | 2017-12-12 | Orthosensor Inc. | Prosthetic component having a compliant surface |
US8701484B2 (en) | 2010-06-29 | 2014-04-22 | Orthosensor Inc. | Small form factor medical sensor structure and method therefor |
US8826733B2 (en) | 2009-06-30 | 2014-09-09 | Orthosensor Inc | Sensored prosthetic component and method |
US8679186B2 (en) | 2010-06-29 | 2014-03-25 | Ortho Sensor Inc. | Hermetically sealed prosthetic component and method therefor |
US9259179B2 (en) | 2012-02-27 | 2016-02-16 | Orthosensor Inc. | Prosthetic knee joint measurement system including energy harvesting and method therefor |
US8714009B2 (en) | 2010-06-29 | 2014-05-06 | Orthosensor Inc. | Shielded capacitor sensor system for medical applications and method |
US8720270B2 (en) | 2010-06-29 | 2014-05-13 | Ortho Sensor Inc. | Prosthetic component for monitoring joint health |
US8907682B2 (en) * | 2009-07-30 | 2014-12-09 | Sensible Medical Innovations Ltd. | System and method for calibration of measurements of interacted EM signals in real time |
US20110103193A1 (en) * | 2009-11-02 | 2011-05-05 | Denis Jimenez | Personal Alert System with Adhesive Fixation |
JP5975879B2 (ja) | 2009-12-01 | 2016-08-23 | キマ メディカル テクノロジーズ リミテッド | 診断装置および診断のためのシステム |
US9161717B2 (en) | 2011-09-23 | 2015-10-20 | Orthosensor Inc. | Orthopedic insert measuring system having a sealed cavity |
CA2805947A1 (fr) | 2010-07-21 | 2012-01-26 | Kyma Medical Technologies Ltd. | Dielectrometre implantable |
CN103281952B (zh) * | 2010-11-03 | 2015-09-23 | 合理医疗创新有限公司 | 电磁探针和其制作方法以及使用这类电磁探针的系统 |
EP2457507B1 (fr) * | 2010-11-24 | 2020-01-01 | eesy-innovation GmbH | Bracelet doté d'un dispositif de détection pour la détection d'un hémogramme |
US20140375335A1 (en) * | 2011-08-26 | 2014-12-25 | Spectral Labs Incorporated | Handheld multisensor contraband detector to improve inspection of personnel at checkpoints |
US9414940B2 (en) | 2011-09-23 | 2016-08-16 | Orthosensor Inc. | Sensored head for a measurement tool for the muscular-skeletal system |
US9839374B2 (en) | 2011-09-23 | 2017-12-12 | Orthosensor Inc. | System and method for vertebral load and location sensing |
US8911448B2 (en) | 2011-09-23 | 2014-12-16 | Orthosensor, Inc | Device and method for enabling an orthopedic tool for parameter measurement |
US9622701B2 (en) | 2012-02-27 | 2017-04-18 | Orthosensor Inc | Muscular-skeletal joint stability detection and method therefor |
US9271675B2 (en) | 2012-02-27 | 2016-03-01 | Orthosensor Inc. | Muscular-skeletal joint stability detection and method therefor |
US9844335B2 (en) | 2012-02-27 | 2017-12-19 | Orthosensor Inc | Measurement device for the muscular-skeletal system having load distribution plates |
US20130317368A1 (en) | 2012-03-12 | 2013-11-28 | Ivwatch, Llc | System for Mitigating the Effects of Tissue Blood Volume Changes to Aid in Diagnosing Infiltration or Extravasation in Animalia Tissue |
WO2013186780A1 (fr) | 2012-06-13 | 2013-12-19 | Hadasit Medical Research Services And Development Ltd. | Dispositifs et procédés de détection de saignement interne et d'hématome |
US9237885B2 (en) | 2012-11-09 | 2016-01-19 | Orthosensor Inc. | Muscular-skeletal tracking system and method |
US9642676B2 (en) | 2013-03-18 | 2017-05-09 | Orthosensor Inc | System and method for measuring slope or tilt of a bone cut on the muscular-skeletal system |
US11793424B2 (en) | 2013-03-18 | 2023-10-24 | Orthosensor, Inc. | Kinetic assessment and alignment of the muscular-skeletal system and method therefor |
US10052064B2 (en) | 2013-04-04 | 2018-08-21 | Thermal Technologies, Inc. | Edema monitor |
US9526438B2 (en) * | 2013-04-26 | 2016-12-27 | University Of Hawaii | Microwave stethoscope for measuring cardio-pulmonary vital signs and lung water content |
US10680324B2 (en) | 2013-10-29 | 2020-06-09 | Zoll Medical Israel Ltd. | Antenna systems and devices and methods of manufacture thereof |
EP4233711A3 (fr) | 2014-02-05 | 2023-10-18 | Zoll Medical Israel Ltd. | Appareils pour déterminer la pression sanguine |
WO2015142384A1 (fr) | 2014-03-21 | 2015-09-24 | Battelle Memorial Institute | Système de balayage de liquide et procédé de vérification et d'identification de médicament par voie intraveineuse |
US10724968B2 (en) | 2014-03-21 | 2020-07-28 | Battelle Memorial Institute | System and method for solution constituent and concentration identification |
WO2016040337A1 (fr) | 2014-09-08 | 2016-03-17 | KYMA Medical Technologies, Inc. | Systèmes et procédés de surveillance et de diagnostic |
US10062958B2 (en) * | 2014-11-21 | 2018-08-28 | Qualcomm Incorporated | Wearable electronic patch with antenna enhancement |
WO2016115175A1 (fr) | 2015-01-12 | 2016-07-21 | KYMA Medical Technologies, Inc. | Systèmes, appareils et procédés permettant de détecter par radio-fréquences la fixation d'un appareil |
TWI573571B (zh) * | 2015-01-30 | 2017-03-11 | 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 | 用以偵測漏液之感應貼片、系統與方法 |
WO2016119211A1 (fr) * | 2015-01-30 | 2016-08-04 | National Taipei University Of Technology | Patch de capteur, système, et procédé de détection de fuite de fluide |
US10856806B2 (en) | 2015-02-12 | 2020-12-08 | University Of Hawaii | Lung water content measurement system and calibration method |
US11154246B2 (en) * | 2016-06-24 | 2021-10-26 | Georgia Tech Research Corporation | Systems and methods of IV infiltration detection |
EP3381370B1 (fr) * | 2017-03-31 | 2019-11-20 | RichHealth Technology Corporation | Timbre transdermique de réseau de micro-aiguilles |
WO2019030746A1 (fr) | 2017-08-10 | 2019-02-14 | Zoll Medical Israel Ltd. | Systèmes, dispositifs et procédés de surveillance physiologique de patients |
EP3681381A1 (fr) | 2017-09-14 | 2020-07-22 | Orthosensor Inc. | Système de détection d'insertion non symétrique et procédé associé |
EP3740852A4 (fr) * | 2018-01-19 | 2021-03-24 | Tactual Labs Co. | Capteur matriciel à isolation de réception |
US10746716B1 (en) | 2019-05-31 | 2020-08-18 | Battelle Memorial Institute | System and method for solution constituent and concentration identification |
US11812978B2 (en) | 2019-10-15 | 2023-11-14 | Orthosensor Inc. | Knee balancing system using patient specific instruments |
CA3228205A1 (fr) | 2020-04-30 | 2021-11-04 | Bayer Healthcare Llc | Systeme, dispositif et procede de sauvegarde du bien-etre de patients pour l'injection d'un liquide |
US20220346661A1 (en) * | 2021-04-29 | 2022-11-03 | Know Labs, Inc. | Antenna array for a non-invasive analyte sensor |
WO2023205697A2 (fr) * | 2022-04-19 | 2023-10-26 | The Johns Hopkins University | Dispositif de détection précoce de perfusion iv pédiatrique |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3618602A (en) * | 1969-08-28 | 1971-11-09 | Robert F Shaw | Liquid infusion infiltration detection apparatus and method |
US4240445A (en) | 1978-10-23 | 1980-12-23 | University Of Utah | Electromagnetic energy coupler/receiver apparatus and method |
US4488559A (en) | 1981-06-30 | 1984-12-18 | University Of Utah | Apparatus and method for measuring lung water content |
US4647281A (en) * | 1985-02-20 | 1987-03-03 | M/A-Com, Inc. | Infiltration detection apparatus |
US4690149A (en) | 1985-10-28 | 1987-09-01 | The Johns Hopkins University | Non-invasive electromagnetic technique for monitoring physiological changes in the brain |
US4877034A (en) | 1987-06-18 | 1989-10-31 | Smith & Nephew, Inc. | Method and device for detection of tissue infiltration |
US5184620A (en) * | 1991-12-26 | 1993-02-09 | Marquette Electronics, Inc. | Method of using a multiple electrode pad assembly |
JPH0579468U (ja) * | 1992-03-27 | 1993-10-29 | 株式会社潤工社 | 漏液検知装置 |
US5334141A (en) | 1992-06-26 | 1994-08-02 | Medrad, Inc. | Extravasation detection system and apparatus |
US5964703A (en) | 1994-01-14 | 1999-10-12 | E-Z-Em, Inc. | Extravasation detection electrode patch |
US5947910A (en) | 1994-01-14 | 1999-09-07 | E-Z-Em, Inc. | Extravasation detection technique |
EP0694282B1 (fr) | 1994-07-01 | 2004-01-02 | Interstitial, LLC | Détection et visualisation du cancer du sein par ondes électromagnétiques millimétriques |
US20010044588A1 (en) * | 1996-02-22 | 2001-11-22 | Mault James R. | Monitoring system |
US5954668A (en) | 1996-06-14 | 1999-09-21 | Medrad, Inc. | Extravasation detector using microwave radiometry |
US6026173A (en) | 1997-07-05 | 2000-02-15 | Svenson; Robert H. | Electromagnetic imaging and therapeutic (EMIT) systems |
US6415170B1 (en) * | 1996-12-09 | 2002-07-02 | 3M Innovative Properties Company | Biomedical electrode and method for its manufacture |
IT1289809B1 (it) * | 1996-12-27 | 1998-10-16 | Ist Trentino Di Cultura | Procedimento e sistema automatico per ottenere mappe di contenuto d'acqua e/o di permettivita'elettrica da immagini di risonanza |
JPH1157001A (ja) * | 1997-08-11 | 1999-03-02 | Suugan Kk | 血管外投与検知装置 |
US6038464A (en) * | 1998-02-09 | 2000-03-14 | Axelgaard Manufacturing Co., Ltd. | Medical electrode |
US6047215A (en) * | 1998-03-06 | 2000-04-04 | Sonique Surgical Systems, Inc. | Method and apparatus for electromagnetically assisted liposuction |
US6233479B1 (en) | 1998-09-15 | 2001-05-15 | The Regents Of The University Of California | Microwave hematoma detector |
US6408204B1 (en) * | 1999-07-28 | 2002-06-18 | Medrad, Inc. | Apparatuses and methods for extravasation detection |
US6300906B1 (en) * | 2000-01-05 | 2001-10-09 | Harris Corporation | Wideband phased array antenna employing increased packaging density laminate structure containing feed network, balun and power divider circuitry |
US6487428B1 (en) * | 2000-08-31 | 2002-11-26 | Trustees Of The University Of Pennsylvania | Extravasation detection apparatus and method based on optical sensing |
ITBO20010110A1 (it) * | 2001-03-01 | 2002-09-01 | Tre Esse Progettazione Biomedi | Procedimento e dispositivo impiantabile per la misura intrapolmonare di proprieta' fisiche del tessuto polmonare dipendenti dalla sua densit |
EP1647306B1 (fr) * | 2001-07-26 | 2012-03-21 | Medrad, Inc. | Capteurs électromagnétiques destinés à des applications sur des tissus biologiques |
US7122012B2 (en) | 2001-07-26 | 2006-10-17 | Medrad, Inc. | Detection of fluids in tissue |
US6980852B2 (en) * | 2002-01-25 | 2005-12-27 | Subqiview Inc. | Film barrier dressing for intravascular tissue monitoring system |
-
2004
- 2004-10-25 JP JP2006536843A patent/JP4511549B2/ja active Active
- 2004-10-25 CN CN200480031430.4A patent/CN100482151C/zh active Active
- 2004-10-25 WO PCT/US2004/035135 patent/WO2005043100A2/fr active Application Filing
- 2004-10-25 EP EP12005361.6A patent/EP2526857B1/fr not_active Not-in-force
- 2004-10-25 US US10/576,333 patent/US8295920B2/en active Active
- 2004-10-25 EP EP04796177.6A patent/EP1675506B1/fr active Active
-
2012
- 2012-09-14 US US13/620,310 patent/US20130274599A1/en not_active Abandoned
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9289550B1 (en) | 2001-02-06 | 2016-03-22 | Bayer Healthcare Llc | Apparatus and method for detecting fluid extravasation |
US11883144B2 (en) | 2011-09-02 | 2024-01-30 | Battelle Memorial Institute | Integrated extravasation and infiltration detection device on a RF isolated flexible substrate with fluid guide to detect fluid changes via signal comparison |
US11883143B2 (en) | 2011-09-02 | 2024-01-30 | Battelle Memorial Institute | Wireless and power-source-free extravasation and infiltration detection sensor circuitry provided on a substrate with signal splitter |
US11986281B2 (en) | 2011-09-02 | 2024-05-21 | Battelle Memorial Institute | Distributed extravasation detection system for fluid change and to control the fluids levels in a body via wireless interface based on rate of activation |
Also Published As
Publication number | Publication date |
---|---|
JP2007509353A (ja) | 2007-04-12 |
CN100482151C (zh) | 2009-04-29 |
WO2005043100A2 (fr) | 2005-05-12 |
US20130274599A1 (en) | 2013-10-17 |
EP2526857A2 (fr) | 2012-11-28 |
EP1675506A2 (fr) | 2006-07-05 |
EP2526857A3 (fr) | 2013-04-03 |
WO2005043100A3 (fr) | 2006-01-05 |
JP4511549B2 (ja) | 2010-07-28 |
EP2526857B1 (fr) | 2015-10-14 |
US8295920B2 (en) | 2012-10-23 |
US20070123770A1 (en) | 2007-05-31 |
CN1870934A (zh) | 2006-11-29 |
EP1675506A4 (fr) | 2010-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1675506B1 (fr) | Systeme pour detecter des variations fluidiques | |
US7122012B2 (en) | Detection of fluids in tissue | |
EP1834667B1 (fr) | Capteurs électromagnétiques destinés à des applications sur des tissus biologiques | |
US11883144B2 (en) | Integrated extravasation and infiltration detection device on a RF isolated flexible substrate with fluid guide to detect fluid changes via signal comparison | |
US6459931B1 (en) | Apparatuses and methods for extravasation detection | |
US7674244B2 (en) | Devices, systems and methods for detecting increase fluid levels in tissue | |
US20240206756A1 (en) | Wireless and Power-Source-Free Extravasation and Infiltration Detection Sensor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060419 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL HR LT LV MK |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20100526 |
|
17Q | First examination report despatched |
Effective date: 20100723 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: MEDRAD, INC. |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BAYER MEDICAL CARE INC. |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20150528 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602004047915 Country of ref document: DE Owner name: BAYER HEALTHCARE LLC, WHIPPANY, US Free format text: FORMER OWNER: MEDRAD, INC., PITTSBURGH, PA., US |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 749109 Country of ref document: AT Kind code of ref document: T Effective date: 20151015 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602004047915 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20151217 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 749109 Country of ref document: AT Kind code of ref document: T Effective date: 20150916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160118 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602004047915 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151031 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151031 |
|
26N | No opposition filed |
Effective date: 20160617 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 13 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151025 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R081 Ref document number: 602004047915 Country of ref document: DE Owner name: BAYER HEALTHCARE LLC, WHIPPANY, US Free format text: FORMER OWNER: BAYER MEDICAL CARE INC., INDIANOLA, PA., US |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: PD Owner name: BAYER HEALTHCARE LLC; US Free format text: DETAILS ASSIGNMENT: CHANGE OF OWNER(S), ASSIGNMENT; FORMER OWNER NAME: BAYER MEDICAL CARE INC. Effective date: 20170215 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E Free format text: REGISTERED BETWEEN 20170223 AND 20170303 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20041025 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP Owner name: BAYER HEALTHCARE LLC, US Effective date: 20170621 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20150916 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 14 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20151025 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 15 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230507 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20230925 Year of fee payment: 20 Ref country code: GB Payment date: 20230921 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20230921 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20230926 Year of fee payment: 20 Ref country code: DE Payment date: 20230919 Year of fee payment: 20 |